Cyclerion Therapeutics, Inc. (CYCN) Financials

CYCN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 15.2 million 2.3 million
2023-06-30 10.1 million 4.9 million
2023-03-31 11.5 million 7.5 million
2022-12-31 18.1 million 7.6 million

CYCN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.9 million 159000
2023-06-30 -6.6 million 379000
2023-03-31 -6.2 million 426000
2022-12-31 -7.0 million 1.1 million

CYCN Net Income

No data available :(

CYCN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 9.1 million - -
2023-06-30 5.6 million - -
2023-03-31 7.2 million - -
2022-12-31 13.4 million - -

CYCN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.8 million
2023-06-30 2.3 million
2023-03-31 2.2 million
2022-12-31 30.4 million

CYCN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 580000 2.1 million -
2023-06-30 - 886000 3.4 million -
2023-03-31 - 3.8 million 3.3 million -
2022-12-31 - 4.5 million 3.5 million -

CYCN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 1.6 million -

CYCN

Price: $2.82

52 week price:
1.75
7.00

Earnings Per Share: -5.39 USD

P/E Ratio: -0.20

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 146600

Market Capitalization: 8.3 million

Links: